# AlphaAgent Healthcare Solutions — Investor Pitch Deck

> **Audience:** Banker → high-net-worth investors / MedTech seed VCs
> **Tone:** Professional, high-growth, technically credible, sober on cost & regulation
> **Format per slide:** Title · Visual · On-slide bullets (punchy) · Speaker notes (narrative)
> **The ask:** ~$500k (with $300k presented as the efficient floor) — see Slide 11
> **Numbers source:** `use_of_funds_model.py` (all figures cited to July 2026 research)

---

## Slide 1 — Title

**Visual:** Clean hero shot — surgeon wearing Vuzix LX1 glasses, calm OR, one line of AI-generated documentation floating in the lens. Logo + tagline.

**On slide:**
- **AlphaAgent Healthcare Solutions**
- *The autonomous documentation layer for the operating room.*
- Smart glasses + agentic AI that document surgery, hands-free.

**Speaker notes:**
"AlphaAgent puts an autonomous AI agent behind a surgeon's eyes. It watches, listens, and writes the clinical record — so the surgeon can stop being a data-entry clerk and go back to being a surgeon. We pair enterprise smart glasses with an AI agent that doesn't just transcribe — it *acts*: it populates the EHR and waits for a one-word voice approval."

---

## Slide 2 — The Problem ("Why Now")

**Visual:** Split screen — LEFT: surgeon hunched over a computer, patient waiting; RIGHT: surgeon pulling a personal phone into a sterile field to snap a wound photo (contamination flag icon).

**On slide:**
- Surgeons lose hours/day to documentation — the #1 driver of clinician burnout.
- Dual-task interference (care + charting) raises error rates.
- Pre/post-op photos are taken on personal phones → **contamination + compliance risk**.
- Existing AI scribes stop at a text note — a human still does the clicking.

**Speaker notes:**
"Two things are broken. First, the surgeon is drowning in charting — and every minute on the keyboard is a minute not on the patient. Second, the visual record — the wound photos, the surgical site — gets captured on a personal phone that has no business in a sterile field. Today's ambient AI scribes help with the *words*, but they don't touch the *images*, and they don't *do* anything — they hand the surgeon a draft to type in. We remove the keyboard and the phone entirely."

---

## Slide 3 — The Solution ("How")

**Visual:** Simple 3-step flow: (1) Glasses capture audio + photos, hands-free → (2) Agent reasons & drafts the record → (3) Surgeon approves/edits by voice; agent writes to EHR.

**On slide:**
- **Capture** — Vuzix LX1 glasses: 12MP photos + OR audio, hands-free, sterile.
- **Reason** — cloud agent with persistent memory turns capture → structured clinical record.
- **Act** — agent writes EHR fields via FHIR; surgeon approves or edits **by voice**.
- Zero phones. Zero keyboards. Surgeon stays with the patient.

**Speaker notes:**
"The workflow is three steps and none of them require the surgeon's hands. The glasses capture the moment. Our agent — not a transcript tool, an *agent* with memory and the ability to make tool calls — turns that into a real clinical record and writes it into the EHR through standard FHIR APIs. The surgeon just says 'approve,' or 'change the laterality to left.' That's it. The documentation is done before they've scrubbed out."

---

## Slide 4 — Product & The Technical Moat ("The Magic")

**Visual:** Layered diagram — Hardware (LX1, on-device Android 15) → Edge pre-processing → Cloud Agent (memory + tools + FHIR) → EHR. Emphasize "PHI processed on-device first."

**On slide:**
- **On-device compute:** LX1 is a full Android 15 computer (8-core Qualcomm, 6GB/128GB, Wi-Fi 6E) → data can be pre-processed **before it leaves the room**.
- **Agentic core:** autonomous agent, persistent memory, deterministic tool-calling, FHIR EHR writes — proprietary, in production-grade TypeScript/Python.
- **Compliance-native stack:** Azure Blob (BAA) for media, GCP Gemini (BAA) for voice.
- **Compounding data flywheel:** every approved record = labeled training data → the agent gets better with use.

**Speaker notes:**
"Here's why this is defensible. The glasses aren't a camera — they're a computer, so patient data can be handled on-device first, which is the first question every hospital CISO asks. And our real IP is the agent: persistent memory, reliable tool-calling, and direct EHR integration. Anyone can call an LLM; very few can make an agent that *reliably acts* inside an enterprise workflow. Every surgery we document generates proprietary, labeled data that no software-only or hardware-only competitor can replicate."

---

## Slide 5 — Why Now

**Visual:** Three converging arrows → "The window is open." Timeline showing LLM/agent capability crossing the reliability line in 2025–2026.

**On slide:**
- **AI agents just got reliable enough to act** — not just chat — in 2025–26.
- **Enterprise smart glasses are finally OR-viable** (on-device compute, quality optics, mics).
- **Hospitals are desperate** — staffing shortages + burnout at all-time highs.
- This product was technically impossible 3 years ago.

**Speaker notes:**
"Investors always ask why now. Three years ago the agents weren't reliable enough to trust with a medical record, and the glasses weren't powerful enough to run anything on-device. Both of those crossed the line in the last 18 months, at exactly the moment hospitals hit a staffing crisis. That convergence is the window — and it won't stay open uncontested."

---

## Slide 6 — Competitive Landscape (THE WEDGE)

**Visual:** 2×2 matrix. **X-axis: Wearable / hands-free capture. Y-axis: Agentic (autonomous action, not just a note).**
- Bottom-left: legacy manual charting.
- Top-left (agentic, no wearable): **Microsoft DAX Copilot, Abridge, Augmedix** — great scribes, but eyes-down and they stop at a draft note.
- Bottom-right (wearable, no agent): **Vuzix** — hardware for factory/field work; no clinical AI agent.
- **Top-right (agentic + wearable + acts): AlphaAgent — alone.**

**On slide:**
- **Microsoft DAX / Abridge:** ambient AI scribes — **no eyewear, no visual capture, and they stop at a note** (human still finalizes).
- **Vuzix:** best-in-class enterprise eyewear — **no agentic AI, not built for the OR.**
- **AlphaAgent:** the only player combining wearable capture + an agent that **autonomously completes the record**.
- Our moat is the *intersection* — a hardware company can't build our agent; a software scribe can't own the sterile visual field.

**Speaker notes:**
"Let me be precise about competition, because 'no competition' is never true. Microsoft's DAX is a real, well-funded ambient scribe — but it's a microphone in the room. It has no eyewear, it never captures the surgical image, and critically it stops at a *draft note* a human still has to act on. Vuzix makes the best enterprise glasses on the market — but they're aimed at factory and field workers and have no clinical agent. We sit in the one quadrant neither can reach: wearable, visual, *and* agentic. To catch us, a software scribe would have to become a hardware company, and a hardware company would have to build our agent. That intersection is the moat."

---

## Slide 7 — Market Opportunity

**Visual:** Concentric TAM/SAM/SOM circles landing inside the $8T global healthcare market. Beachhead → expansion arrow.

**On slide:**
- **Beachhead (SOM):** high-volume surgical specialties (ortho, general, plastics) in US hospitals & ASCs.
- **SAM:** US clinical documentation + surgical workflow.
- **TAM:** $8T global healthcare; documentation & workflow automation.
- **Wedge → platform:** own the OR capture layer today → expand to automated diagnostics on proprietary data.

**Speaker notes:**
"We start narrow and deep: high-volume surgical specialties where documentation pain is worst and photos matter most. That's our beachhead. But the real story is the flywheel — once we own the moment of capture in the OR, we sit on a proprietary multimodal surgical dataset that opens the door to diagnostics and decision support inside an $8 trillion market. Land the workflow, expand to intelligence."

---

## Slide 8 — Business Model

**Visual:** B2B SaaS funnel: hospital/ASC → per-seat/per-surgeon subscription → expansion. Hardware as enabler, not margin.

**On slide:**
- **B2B SaaS:** recurring per-surgeon / per-seat subscription to hospitals, surgical groups, ASCs.
- **Hardware = enabler**, not the margin — sold/bundled at low markup to drive software adoption.
- **Land-and-expand:** one service line → whole department → hospital system.
- Sticky by design: once it's in the workflow, ripping it out means going back to the keyboard.

**Speaker notes:**
"We make money on software, not glasses. The hardware is the wedge that gets us into the OR; the recurring revenue is the per-surgeon subscription. We land in one service line, prove the time savings, and expand across the department and then the system. And it's sticky — once a surgeon has worked hands-free, going back to manual charting is unthinkable. That's word-of-mouth growth inside a hospital."

---

## Slide 9 — Regulatory & Path to Market (Moat + Safety)

**Visual:** Timeline: HIPAA/SOC 2 → ISO 13485 QMS → FDA Pre-Sub (Q3) → Pilots → 510(k) submission (2027).

**On slide:**
- **Pathway:** Class II **510(k)**, predicate = surgical lighting/headwear; **lean QMS from day one.**
- **Q3 2026:** FDA Pre-Submission to lock testing protocol.
- **Compliance-native:** HIPAA + SOC 2 + ISO 13485 built in, not bolted on.
- **Honest milestone:** this round funds cleared *pathway* + live pilots; full **510(k) clearance completes ~2027** (next round).

**Speaker notes:**
"Regulation is a moat if you treat it as one. We're pursuing a Class II 510(k) with a lean quality system from day one, and our Pre-Submission this quarter locks the testing protocol with the FDA. I want to be straight with you: this round gets us to a validated pathway and live hospital pilots — full clearance lands in 2027 on the next round. That's not a weakness; that's the exact inflection that de-risks the Series A, and it's why the regulatory work is a barrier to everyone chasing us."

---

## Slide 10 — Team

**Visual:** Two founder headshots with credibility badges (HCA Healthcare Analytics · Raytheon · Cornell MSBA).

**On slide:**
- **Nathanael Gill — CEO.** AI/agent systems + healthcare data & HIPAA (HCA Healthcare analytics). Builds the software & agent.
- **Manny Figueroa — CTO.** Mechanical/systems engineer, Raytheon (military-grade hardware). Leads hardware.
- Met & worked together in-person via Cornell MSBA.
- **Founder-market fit:** the exact software + hardware pairing this product requires.

**Speaker notes:**
"This is a hardware-and-software product, and we're a hardware-and-software team. I build the agent and I know the healthcare data pipelines and HIPAA rules from the inside at HCA. Manny builds reliability-critical hardware at Raytheon — precisely the discipline you want when your device goes into an operating room. You need both to build this, and few teams have both."

---

## Slide 11 — The Ask & Use of Funds

**Visual:** Three-column table (Lean / Standard / Aggressive) with the bucket bars: Hardware · Regulatory · Runway. Highlight the $500k column; footnote the $300k floor.

**On slide:**
- **Raising ~$500k** to reach multi-hospital pilots with the FDA machine underway.
- **Use of funds (midpoint burn):**
  - Hardware & manufacturing (LX1 fleet + post-pilot tooling): **~$103k**
  - Regulatory & compliance (QMS + HIPAA/SOC 2 + 510(k) started): **~$204k**
  - 18-mo solo runway + Manny (post-pilot) + cloud: **~$219k**
- **$300k = efficient floor** (12-mo runway, Pre-Sub, single-site pilots on off-the-shelf Vuzix).
- **Capital-efficient:** one salaried founder; Manny equity-only until the pilot proves the wedge.
- **Framing:** *"We prove the wedge on $100k; we clear the regulatory moat on $500k."*

**Speaker notes:**
"We're raising roughly $500k. Here's exactly where it goes, bottoms-up. About a fifth is hardware — the LX1 fleet plus enclosure tooling. Roughly $200k is the regulatory moat — the quality system, HIPAA and SOC 2, and getting the 510(k) underway. The rest is an 18-month runway for a lean team plus our first technical hire. If an investor wants the efficient version, $300k gets us a 12-month runway and single-site pilots. What I won't tell you is that we can do this on $100k — a $100k round only funds a demo. The 'medical' in medical device carries a real regulatory premium, and we've priced it honestly."

---

## Slide 12 — Vision / Close

**Visual:** Forward shot — the agent layer expanding from documentation → diagnostics across a hospital system.

**On slide:**
- Today: kill documentation friction in the OR.
- Tomorrow: the intelligent capture-and-action layer for all of surgery.
- Building the proprietary surgical dataset that powers automated diagnostics.
- **Own the surgeon's point of view — own the future of the OR.**

**Speaker notes:**
"Documentation is the wedge, not the destination. Whoever owns the moment of capture in the operating room — the surgeon's point of view — owns the data layer that the next decade of surgical AI will be built on. That's what we're building, and this round is how it starts."

---

## Appendix — Deal-desk backup (don't present; keep ready)

- **Full Use-of-Funds model:** `use_of_funds_model.py` — Lean ~$110k / Standard ~$250k / Aggressive ~$525k midpoint burn (solo salaried founder; Manny equity-only until post-pilot); every line cited.
- **Key cost anchors (July 2026):** Vuzix LX1 $2,199.99/unit · ISO 13485 QMS $30–60k · HIPAA/SOC 2 $20–80k yr1 · 510(k) all-in $50–250k+ (FY26 user fee $6,517 small-biz / $26,067 std) · aluminum bridge tooling $3–25k.
- **Honest risks to pre-empt:** (1) full 510(k) clearance is next round; (2) DAX/Abridge are real, well-funded — our answer is the wearable+agentic intersection; (3) hospital sales cycles are long — mitigated by starting with ASCs / design partners.
